Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)
McGill University Health Centre/Research Institute of the McGill University Health Centre
McGill University Health Centre/Research Institute of the McGill University Health Centre
Aurigene Discovery Technologies Limited
ImmunityBio, Inc.
Instil Bio
Cancer Trials Ireland
Deciphera Pharmaceuticals, LLC
Gustave Roussy, Cancer Campus, Grand Paris
Roswell Park Cancer Institute
Taiho Oncology, Inc.
Therapex Co., Ltd
Sotio Biotech Inc.
Imugene Limited
The Methodist Hospital Research Institute
Pfizer
M.D. Anderson Cancer Center
AstraZeneca